17-75827639-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_199242.3(UNC13D):​c.*326C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0502 in 1,535,128 control chromosomes in the GnomAD database, including 3,014 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.083 ( 873 hom., cov: 33)
Exomes 𝑓: 0.047 ( 2141 hom. )

Consequence

UNC13D
NM_199242.3 3_prime_UTR

Scores

1
12

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.0640

Publications

7 publications found
Variant links:
Genes affected
UNC13D (HGNC:23147): (unc-13 homolog D) This gene encodes a protein that is a member of the UNC13 family, containing similar domain structure as other family members but lacking an N-terminal phorbol ester-binding C1 domain present in other Munc13 proteins. The protein appears to play a role in vesicle maturation during exocytosis and is involved in regulation of cytolytic granules secretion. Mutations in this gene are associated with familial hemophagocytic lymphohistiocytosis type 3, a genetically heterogeneous, rare autosomal recessive disorder. [provided by RefSeq, Jul 2008]
UNC13D Gene-Disease associations (from GenCC):
  • familial hemophagocytic lymphohistiocytosis 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
  • hereditary hemophagocytic lymphohistiocytosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0011135638).
BP6
Variant 17-75827639-G-A is Benign according to our data. Variant chr17-75827639-G-A is described in ClinVar as [Benign]. Clinvar id is 325237.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.185 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
UNC13DNM_199242.3 linkc.*326C>T 3_prime_UTR_variant Exon 32 of 32 ENST00000207549.9 NP_954712.1 Q70J99-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
UNC13DENST00000207549.9 linkc.*326C>T 3_prime_UTR_variant Exon 32 of 32 1 NM_199242.3 ENSP00000207549.3 Q70J99-1
UNC13DENST00000412096.6 linkc.3260C>T p.Ser1087Phe missense_variant Exon 33 of 33 2 ENSP00000388093.1 Q70J99-3
UNC13DENST00000699510.1 linkc.*326C>T 3_prime_UTR_variant Exon 20 of 20 ENSP00000514405.1 A0A8V8TNG5
UNC13DENST00000589670.5 linkc.*9-194C>T intron_variant Intron 3 of 3 3 ENSP00000466758.1 K7EN29

Frequencies

GnomAD3 genomes
AF:
0.0832
AC:
12657
AN:
152176
Hom.:
868
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.188
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.0473
Gnomad ASJ
AF:
0.0622
Gnomad EAS
AF:
0.000577
Gnomad SAS
AF:
0.0616
Gnomad FIN
AF:
0.0341
Gnomad MID
AF:
0.0828
Gnomad NFE
AF:
0.0455
Gnomad OTH
AF:
0.0664
GnomAD2 exomes
AF:
0.0485
AC:
6332
AN:
130544
AF XY:
0.0503
show subpopulations
Gnomad AFR exome
AF:
0.199
Gnomad AMR exome
AF:
0.0267
Gnomad ASJ exome
AF:
0.0569
Gnomad EAS exome
AF:
0.000288
Gnomad FIN exome
AF:
0.0316
Gnomad NFE exome
AF:
0.0429
Gnomad OTH exome
AF:
0.0527
GnomAD4 exome
AF:
0.0466
AC:
64420
AN:
1382834
Hom.:
2141
Cov.:
31
AF XY:
0.0473
AC XY:
32255
AN XY:
682258
show subpopulations
African (AFR)
AF:
0.205
AC:
6463
AN:
31586
American (AMR)
AF:
0.0300
AC:
1069
AN:
35674
Ashkenazi Jewish (ASJ)
AF:
0.0560
AC:
1409
AN:
25164
East Asian (EAS)
AF:
0.000168
AC:
6
AN:
35724
South Asian (SAS)
AF:
0.0677
AC:
5361
AN:
79194
European-Finnish (FIN)
AF:
0.0365
AC:
1222
AN:
33462
Middle Eastern (MID)
AF:
0.0797
AC:
450
AN:
5646
European-Non Finnish (NFE)
AF:
0.0420
AC:
45315
AN:
1078518
Other (OTH)
AF:
0.0540
AC:
3125
AN:
57866
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
3986
7972
11959
15945
19931
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1768
3536
5304
7072
8840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0833
AC:
12684
AN:
152294
Hom.:
873
Cov.:
33
AF XY:
0.0817
AC XY:
6082
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.188
AC:
7822
AN:
41528
American (AMR)
AF:
0.0471
AC:
721
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0622
AC:
216
AN:
3472
East Asian (EAS)
AF:
0.000578
AC:
3
AN:
5188
South Asian (SAS)
AF:
0.0621
AC:
300
AN:
4832
European-Finnish (FIN)
AF:
0.0341
AC:
362
AN:
10626
Middle Eastern (MID)
AF:
0.0822
AC:
24
AN:
292
European-Non Finnish (NFE)
AF:
0.0455
AC:
3096
AN:
68032
Other (OTH)
AF:
0.0652
AC:
138
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
568
1136
1703
2271
2839
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
126
252
378
504
630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0562
Hom.:
279
Bravo
AF:
0.0874
TwinsUK
AF:
0.0402
AC:
149
ALSPAC
AF:
0.0441
AC:
170
ExAC
AF:
0.0430
AC:
819
Asia WGS
AF:
0.0350
AC:
121
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Familial hemophagocytic lymphohistiocytosis 3 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.63
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
3.0
DANN
Benign
0.60
Eigen
Benign
-0.55
Eigen_PC
Benign
-0.74
FATHMM_MKL
Benign
0.059
N
LIST_S2
Benign
0.26
T
MetaRNN
Benign
0.0011
T
MetaSVM
Benign
-1.1
T
PhyloP100
0.064
PROVEAN
Benign
-0.34
N
REVEL
Benign
0.049
Sift
Pathogenic
0.0
D
Vest4
0.056
ClinPred
0.0065
T
GERP RS
1.6
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9916685; hg19: chr17-73823720; API